We have worked with Companies that have spun out of:
Oxford University Cambridge University Manchester University Leeds University AstraZeneca
Pfizer Amgen University of Strathclyde Kings College Royal Veterinary College
Warwick University Bristol University Liverpool University Sheffield University
Client Highlights
Acting for Blueberry Therapeutics Limited in relation to its acquisition of certain assets from AstraZeneca, its seed funding from various high net worth investors, its fundraise led by the GM&C Life Science Fund and its Series B funding by CMS Medical Venture (Investments) Limited.
Advising Talisman Therapeutics Limited on its spin out from Cambridge University including a collaboration agreement with MedImmunne.
Advising Alderley Analytical Limited on its formation and funding round with Alderley Park Ventures and SPARK Impact.
Advising Ubiquigent Limited , a spinout from Dundee University on its seed funding from Scottish Enterprise and IP2IPO Group.
Advising Manchester Imaging Limited on its original spinout from Manchester University, its subsequent first round funding by Mercia Fund and on its first commercial agreement with Henry Schien Inc.
Advising Clin-E-Cal Limited on its spinout from Manchester University and its subsequent investment rounds.
Advising BiVictrix Therapeutics Limited on its investment rounds with Alderley Park Ventures Limited and DBW Investments Limited, to eventual trading on the London Stock Exchange.
Made with FlippingBook - Online catalogs